Literature DB >> 5107690

Fungal burn wound infection.

G Nash, F D Foley, M N Goodwin, H M Bruck, K A Greenwald, B A Pruitt.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 5107690

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

1.  Surveillance of nosocomial fungal infections in a burn care unit.

Authors:  A Chakrabarti; N Nayak; P S Kumar; P Talwar; P S Chari; D Panigrahi
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 2.  Cutaneous aspergillosis.

Authors:  J A van Burik; R Colven; D H Spach
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Zygomycotic gangrenous cellulitis in a patient with non-insulin dependent diabetes mellitus.

Authors:  O Zimhony; E Israeli; S D Malnick; A Pansky; P Cohen; D Geltner
Journal:  West J Med       Date:  1998-03

Review 4.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

5.  Studies on the occurrence and significance of yeasts and fungi in the burn wound.

Authors:  H M Bruck; G Nash; J M Stein; R B Lindberg
Journal:  Ann Surg       Date:  1972-07       Impact factor: 12.969

Review 6.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

7.  Candida sepsis: pathogenesis and principles of treatments.

Authors:  H H Stone; L D Kolb; C A Currie; C E Geheber; J Z Cuzzell
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

Review 8.  Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.

Authors:  T J Walsh; D M Dixon
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

9.  In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

Authors:  Qiu N Sun; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

10.  Rhizopus rhizopodiformis: emerging etiological agent of mucormycosis.

Authors:  E J Bottone; I Weitzman; B A Hanna
Journal:  J Clin Microbiol       Date:  1979-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.